BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11030038)

  • 21. [Laparoscopic subtotal splenectomy in the treatment of hereditary spherocytosis].
    Vasilescu C; Stănciulea O; Coliţă A; Stoia R; Moicean A; Arion C
    Chirurgia (Bucur); 2003; 98(6):571-6. PubMed ID: 15143616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations.
    Margetis P; Antonelou M; Karababa F; Loutradi A; Margaritis L; Papassideri I
    Blood Cells Mol Dis; 2007; 38(3):210-20. PubMed ID: 17208471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical expression and laboratory detection of red blood cell membrane protein mutations.
    Palek J; Jarolim P
    Semin Hematol; 1993 Oct; 30(4):249-83. PubMed ID: 8266114
    [No Abstract]   [Full Text] [Related]  

  • 24. Genotype-phenotype correlation in children with hereditary spherocytosis.
    Tole S; Dhir P; Pugi J; Drury LJ; Butchart S; Fantauzzi M; Langer JC; Baker JM; Blanchette VS; Kirby-Allen M; Carcao MD
    Br J Haematol; 2020 Nov; 191(3):486-496. PubMed ID: 32436265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of the erythrocyte membrane.
    Gallagher PG
    Pediatr Clin North Am; 2013 Dec; 60(6):1349-62. PubMed ID: 24237975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele.
    Miraglia del Giudice E; Francese M; Polito R; Nobili B; Iolascon A; Perrotta S
    Haematologica; 1997; 82(3):332-3. PubMed ID: 9234582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenectomy for hereditary spherocytosis: complete, partial or not at all?
    Casale M; Perrotta S
    Expert Rev Hematol; 2011 Dec; 4(6):627-35. PubMed ID: 22077527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the clinical spectrum and genetics of red blood cell membrane disorders.
    Gallagher PG
    Curr Hematol Rep; 2004 Mar; 3(2):85-91. PubMed ID: 14965483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Megaloblastic anemia due to folate deficiency associated with hereditary spherocytosis].
    Mori H; Takahashi N; Tada J; Higuchi T; Shimizu T; Harada H; Maeda T; Miyoshi Y; Okada S; Niikura H
    Rinsho Ketsueki; 1994 Apr; 35(4):397-402. PubMed ID: 8028187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary spherocytosis.
    Shah S; Vega R
    Pediatr Rev; 2004 May; 25(5):168-72. PubMed ID: 15121908
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in understanding the pathogenesis of red cell membrane disorders.
    Iolascon A; Andolfo I; Russo R
    Br J Haematol; 2019 Oct; 187(1):13-24. PubMed ID: 31364155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary spherocytosis: Retrospective evaluation of 65 children.
    Güngör A; Yaralı N; Fettah A; Ok-Bozkaya İ; Özbek N; Kara A
    Turk J Pediatr; 2018; 60(3):264-269. PubMed ID: 30511538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematologically important mutations: ankyrin variants in hereditary spherocytosis.
    Gallagher PG
    Blood Cells Mol Dis; 2005; 35(3):345-7. PubMed ID: 16223590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary spherocytosis.
    Perrotta S; Gallagher PG; Mohandas N
    Lancet; 2008 Oct; 372(9647):1411-26. PubMed ID: 18940465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect.
    Mariani M; Barcellini W; Vercellati C; Marcello AP; Fermo E; Pedotti P; Boschetti C; Zanella A
    Haematologica; 2008 Sep; 93(9):1310-7. PubMed ID: 18641031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary spherocytosis.
    Boyd AS
    Am Fam Physician; 1989 Feb; 39(2):167-72. PubMed ID: 2644787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial splenic embolization in children with hereditary spherocytosis.
    Pratl B; Benesch M; Lackner H; Portugaller HR; Pusswald B; Sovinz P; Schwinger W; Moser A; Urban C
    Eur J Haematol; 2008 Jan; 80(1):76-80. PubMed ID: 18028435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile of hereditary spherocytosis in North India.
    Panigrahi I; Phadke SR; Agarwal A; Gambhir S; Agarwal SS
    J Assoc Physicians India; 2002 Nov; 50():1360-7. PubMed ID: 12583462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis.
    Rocha S; Vitorino RM; Lemos-Amado FM; Castro EB; Rocha-Pereira P; Barbot J; Cleto E; Ferreira F; Quintanilha A; Belo L; Santos-Silva A
    Blood Cells Mol Dis; 2008; 41(1):5-9. PubMed ID: 18387321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.